SERA - Sera Prognostics Inc - Ordinary Shares Class A
IEX Last Trade
7.35
0.360 4.898%
Share volume: 51,536
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.99
0.36
5.15%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-09 | 2023-03-22 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-03-20 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 125.056 M | 116.561 M | 116.329 M | 105.610 M | 96.680 M | 90.057 M | 95.441 M | 89.886 M | |
| Current Assets | 108.049 M | 90.839 M | 90.125 M | 72.110 M | 64.428 M | 47.546 M | 61.344 M | 53.846 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.009 M | 1.954 M | 1.308 M | 1.202 M | 444.000 K | 1.275 M | 795.000 K | 756.000 K | |
| Short Term Investments | 1.009 M | 1.954 M | 1.308 M | 1.202 M | 444.000 K | 1.275 M | 795.000 K | 756.000 K | |
| Total Receivables | 128.000 K | 107.000 K | 6.113 M | 120.000 K | 163.000 K | 155.000 K | 11.470 M | 117.000 K | |
| Current Cash | 106.912 M | 88.778 M | 82.704 M | 70.788 M | 63.821 M | 46.116 M | 49.079 M | 52.973 M | |
| Total Non-current Assets | 17.007 M | 25.722 M | 26.204 M | 33.500 M | 32.252 M | 42.511 M | 34.097 M | 36.040 M | |
| Property Plant Equipment | 2.967 M | 3.107 M | 3.059 M | 2.907 M | 2.411 M | 2.197 M | 1.999 M | 1.808 M | |
| Other Assets | 363.000 K | 237.000 K | 1.816 M | 1.676 M | 1.534 M | 1.392 M | 1.257 M | 1.846 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 125.056 M | 116.561 M | 116.329 M | 105.610 M | 96.680 M | 90.057 M | 95.441 M | 89.886 M | |
| Total liabilities | 8.151 M | 9.402 M | 17.386 M | 15.400 M | 15.543 M | 14.646 M | 25.283 M | 25.136 M | |
| Total current liabilities | 7.303 M | 8.667 M | 15.538 M | 13.800 M | 14.183 M | 13.545 M | 24.443 M | 24.568 M | |
| Accounts Payable | 783.000 K | 1.088 M | 1.548 M | 1.590 M | 1.244 M | 1.177 M | 1.046 M | 1.026 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 456.000 K | 472.000 K | 464.000 K | 451.000 K | 446.000 K | 438.000 K | 440.000 K | 448.000 K | |
| Long term debt | 848.000 K | 735.000 K | 1.848 M | 1.600 M | 1.360 M | 1.101 M | 840.000 K | 568.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 116.905 M | 107.159 M | 98.943 M | 90.210 M | 81.137 M | 75.411 M | 70.158 M | 64.750 M | |
| Common stock | 30.946 M | 31.006 M | 31.021 M | 31.019 M | 31.077 M | 31.286 M | 31.420 M | 32.220 M | |
| Retained earnings | -190.196 M | -200.908 M | -210.654 M | -221.219 M | -231.761 M | -238.971 M | -246.896 M | -254.993 M |